Stockscreener 앱 받기
92.51
0.60%
0.55
시간 외 거래:
94.36
1.85
+2.00%
전일 마감가:
$91.96
열려 있는:
$91.56
하루 거래량:
157.04K
Relative Volume:
2.09
시가총액:
$4.23B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-10.79%
1개월 성능:
-0.87%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$89.10
$93.99
1주일 범위
$88.49
$105.89
52주 변동 폭
$88.00
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
BLLN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
92.51 | 4.21B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
562.56 | 214.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
222.63 | 158.72B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
695.60 | 55.35B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
136.66 | 39.40B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
221.43 | 37.75B | 15.90B | 1.28B | 2.21B | 7.2842 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-01 | 개시 | BTIG Research | Buy |
| 2025-12-01 | 개시 | JP Morgan | Overweight |
| 2025-12-01 | 개시 | Jefferies | Hold |
| 2025-12-01 | 개시 | Piper Sandler | Overweight |
| 2025-12-01 | 개시 | Stifel | Buy |
| 2025-12-01 | 개시 | Wells Fargo | Equal Weight |
| 2025-12-01 | 개시 | William Blair | Outperform |
모두보기
Billiontoone Inc 주식(BLLN)의 최신 뉴스
BillionToOne’s Earnings Call: Strong Growth and Strategic Outlook - TipRanks
Transcript : BillionToOne, Inc., Q3 2025 Earnings Call, Dec 09, 2025 - marketscreener.com
These Bay Area companies are IPO contenders in 2026 - The Business Journals
BillionToOne, Inc.: Strong Financial Performance and Strategic Market Positioning Drive Buy Rating - TipRanks
BillionToOne (BLLN) Revenue Surge Tests Bullish Growth Narrative Despite Ongoing EPS Losses - Sahm
BillionToOne, Inc.: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
BillionToOne, Inc. SEC 10-Q Report - TradingView — Track All Markets
BillionToOne stock rating reiterated at Overweight by Piper Sandler - Investing.com South Africa
Jim Cramer Says BillionToOne Has a “Fantastic Story” Within the Diagnostics Space - MSN
BillionToOne price target lowered to $145 from $150 at JPMorgan - TipRanks
BillionToOne Swings To Profit In Q3; Sees Q4 Revenue Soaring Up To 100% - Nasdaq
BillionToOne’s Strong Growth Potential and Strategic Integration Drive Buy Rating - TipRanks
BTIG Reiterates 'Buy' Rating for BillionToOne (BLLN) with PT of $160 | BLLN Stock News - GuruFocus
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% By Investing.com - Investing.com Nigeria
Billiontoone Q3 2025 Earnings Call Transcript - MarketBeat
BillionToOne Q3 2025 presentation slides: Revenue soars 117% as profitability achieved - Investing.com Canada
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% - Investing.com
Earnings call transcript: BillionToOne's strong Q3 2025 lifts stock 3.19% - Investing.com
BillionToOne appoints Genmab CFO Anthony Pagano to board - Investing.com
BillionToOne sees Q4 revenue $84M-$90M, consensus $80.14M - TipRanks
BillionToOne Appoints Anthony Pagano as Audit Chair - TipRanks
BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours - marketscreener.com
BillionToOne reports Q3 EPS 10c, consensus 16c - TipRanks
BillionToOne appoints Genmab CFO Anthony Pagano to board By Investing.com - Investing.com India
BillionToOne Appoints Anthony Pagano to Board and Audit Committee - TradingView — Track All Markets
BillionToOne sees FY25 revenue $293M-$299M, consensus $288.61M - TipRanks
(BLLN) BillionToOne Expects Full Year 2025 Revenue Range $293M$299M, vs. FactSet Est of $288.6M - marketscreener.com
Earnings Flash (BLLN) BillionToOne Posts Q3 EPS $0.10, vs. FactSet Est of $0.14 - marketscreener.com
(BLLN) BillionToOne, Inc. Expects Q4 Revenue Range $84.0M$90.0M - marketscreener.com
Earnings Flash (BLLN) BillionToOne, Inc. Reports Q3 Revenue $83.5M, vs. FactSet Est of $82.9M - marketscreener.com
BillionToOne Reports Third Quarter 2025 Results - The Manila Times
BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair - StreetInsider
Is BillionToOne’s Triple Digit Share Price Justified After Recent Volatility and Growth Hopes? - Yahoo Finance
Reassessing BillionToOne (BLLN) Valuation After a Recent Share Price Rebound - Yahoo Finance
BillionToOne initiated with an Overweight at JPMorgan - MSN
BillionToOne2025 Funding Rounds & List of Investors - Tracxn
BillionToOne, Inc.: Target Price Consensus and Analysts Recommendations | BLLN | US0901681058 - marketscreener.com
BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests - MSN
Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
BillionToOne initiated with a Hold at Jefferies - MSN
BillionToOne initiated with an Overweight at Piper Sandler - MSN
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 - The Manila Times
Billiontoone (NASDAQ:BLLN) Coverage Initiated by Analysts at JPMorgan Chase & Co. - Defense World
Piper Sandler initiates BillionToOne stock coverage with Overweight rating By Investing.com - Investing.com South Africa
BillionToOne stock initiated at Overweight by JPMorgan on diagnostic tech - Investing.com Canada
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth - Investing.com Nigeria
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth By Investing.com - Investing.com South Africa
BillionToOne stock initiated at Equal Weight by Wells Fargo with $110 target - Investing.com Australia
BillionToOne Analysts Praise Molecular Diagnostic Firm's IPO RallyBillionToOne (NASDAQ:BLLN) - Benzinga
BillionToOne initiated with an Equal Weight at Wells Fargo - MSN
BillionToOne wins bullish backing, but Jefferies and Wells Fargo urge caution - Investing.com Canada
Billiontoone Inc (BLLN) 재무 분석
Billiontoone Inc (BLLN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.25%
0.89%
자본화:
|
볼륨(24시간):